Bharat Biotech’s Coronavirus Vaccine COVAXIN start a trial on children below 18 years was started at AIIMS, Patna.
COVAXIN Trail was started following a nod given on 11th May by Drugs Controller General of India to conduct clinical trials of Covaxin. Coronavirus Vaccine was approved by DCGI, for Phase II/III clinical trials in age group of 2 to 18 years.
India’s Vaccination Drive
India started world’s largest vaccination drive on 16th January 2021 in phased manner. In 1st phase, healthcare workers were vaccinated. Vaccination of frontline workers started on 2nd February while, those over 60 years of age and for people aged 45 with specified comorbid conditions were allowed to take jab, March onwards under phase 1 itself. On 1st April, 2nd phase started and India allowed all people aged more than 45 under vaccination plan. 3rd phase of vaccination started on May to cover people aged 18-44 years.
India’s Covid-19 Vaccines
India is administering 3 Coronavirus vaccines including Covaxin by Bharat Biotech, COVISHIELD by Serum Institute and Sputnik V by Russia. All these vaccines are being manufactured in India. However, due to shortage of vaccine in the country that actively contributed towards COVAX programme by World Health Organization, no of vaccination per day has decreased from 35 lakh each day in first week of April to 16 lakh doses in May. Companies are increasing vaccine production to build up vaccine stock but it will take time. COVAXIN is expected to produce 3.5 crore vaccines in June, COVISHIELD to produce 10 crore shots.
COVAXIN trial on children begins COVAXIN trial on children begins